> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Public Meeting on Biosimilar User Fee Reauthorization
- URL: https://www.fdaweb.com/public-meeting-on-biosimilar-user-fee-reauthorization/
- Published: 2021-09-21T12:00:00.000Z
- Updated: 2026-09-14T17:15:32.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5150183

*Federal Register* notice: FDA has announced an 11/2 virtual public meeting to discuss proposed recommendations for the reauthorization of the Biosimilar User Fee Act for fiscal years 2023 through 2027\. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-20432.pdf?ref=fdaweb.com).